Elekta to improve machine quality management with vendor-neutral system

Agreement with Acumyn to commercialize AQUA quality management system (QMS)

Toronto Canada — Monday, December 1, 2014

Elekta has entered into an exclusive agreement with Acumyn Inc., a spin-off company from the University Health Network, Toronto to commercialize its integrated Quality Management System, AQUA. The system enables multiple mechanical, dosimetric and imaging QA tests to be conducted, analyzed and reported across the radiotherapy clinic.

Dee Mathieson, Senior Vice President, Oncology Business Line Management at Elekta says: “AQUA fills a big gap that customers have today. A linear accelerator and associated devices need to be calibrated and maintained on a regular basis. AQUA provides a software link between all the disparate systems and manages the workload, scheduling and reporting of routine QA tasks.”

The Elekta version of the AQUA system has been developed in collaboration with Princess Margaret Cancer Centre in Toronto, one of Elekta’s long-standing innovation partners, and is based on a system version that has been in use for over a year, connecting more than 20 machines.

Mathieson adds: “Because AQUA has been developed from a QMS already in clinical practice, it very closely matches the practical, day-to-day requirements of our customers. The system follows Elekta’s open source philosophy and will seamlessly link a range of equipment – regardless of vendor – throughout a typical radiotherapy department.”

Other features of the AQUA quality management system include:

  • Workflow automation and streamlining
  • Aligned to regulatory and professional body guidelines
  • Centralized QA Information Management (database)
  • Real-time auto alerts to areas requiring immediate attention.

Elekta will initially pilot AQUA at selected sites before adding it to its commercial portfolio.



About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,800 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on NASDAQ Stockholm. Website: www.elekta.com Twitter: @Elekta.

About Acumyn
Acumyn is a spin-off company from Princess Margaret Cancer Centre and University Health Network, Toronto, Ontario, Canada. A highly focused research and development company, Acumyn is commercializing a department-level machine quality control software platform for radiation therapy devices. With its software platform, Acumyn helps clinics provide radiation therapy treatment with full confidence, enabling clinicians to cure more cancer patients than ever before by exploiting full performance potential of their devices and using high-precision techniques. Website: www.acumyn.com.

Press Releases

For further information, please contact

Gert van Santen, Group Vice President Corporate Communications, Elekta AB
Tel: +31 653 561 242
Email: gert.vansanten@elekta.com
Time zone: CET: Central European Time

Kris Walmsley, Corporate Communications Manager, Elekta AB
Tel: +46 70 537 9545
Email: kris.walmsley@elekta.com
Time zone: CET: Central European Time